Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death

Predicting defibrillator benefit in patients with cardiac resynchronization therapy: A competing risk study

(2019) Dorothea Weber et al.   HEART RHYTHM

Very long-term survival and late sudden cardiac death in cardiac resynchronization therapy patients

(2019) Sérgio Barra et al.   EUROPEAN HEART JOURNAL

Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study

(2019) Axel Bauer et al.   LANCET

Differential multivariable risk prediction of appropriate shock versus competing mortality - A prospective cohort study to estimate benefits from ICD therapy

(2018) Leonard Bergau et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Application and comparison of the FADES, MADIT, and SHFM-D risk models for risk stratification of prophylactic implantable cardioverter-defibrillator treatment

(2017) Aafke C. van der Heijden et al.   EUROPACE

Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator

(2017) M. van Barreveld et al.   Netherlands Heart Journal

Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

(2016) Lars Køber et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Risk Stratification for Primary Prevention Implantable Cardioverter DefibrillatorsCLINICAL PERSPECTIVE

(2015) Douglas S. Lee et al.   Circulation-Heart Failure

Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement

(2015) G. S. Collins et al.   BMJ-British Medical Journal

Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement

(2015) G. S. Collins et al.   BMJ-British Medical Journal

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy

(2014)   EUROPEAN HEART JOURNAL

The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy

(2013) M. Disertori et al.   EUROPACE

Early mortality in prophylactic implantable cardioverter-defibrillator recipients: development and validation of a clinical risk score

(2013) K. Kraaier et al.   EUROPACE

Applicability of a Risk Score for Prediction of the Long-Term (8-Year) Benefit of the Implantable Cardioverter-Defibrillator

(2012) Alon Barsheshet et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Are complications of implantable defibrillators under-estimated and benefits over-estimated?

(2009) M. Brignole   EUROPACE

A Critical Appraisal of Implantable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death

(2008) Roderick Tung et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY